Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2001 Jan;16(1):60–64. doi: 10.1007/BF02867569

Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas

M S Ghadge 1,✉, A V Sirsat 1, M S Bhansali 3, L J Desouza 3, P Jagannath 3
PMCID: PMC3453617  PMID: 23105293

Abstract

Serum levels of leucine amino peptidase (LAP) was studied along with bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), gamma glutamyl transpeptidase (GGT), alkaline phosphatase (ALP) and the ratio of AST/ALT and GGT/AST in 25 healthy subjects and 52 patients with hepatobiliary malignancies of which 12 were with hepatocellular carcinoma, 12 with liver metastasis, 6 with obstructive jaundice, 9 with carcinoma of gall bladder, 6 with carcinoma of pancreas and 7 with periampullary carcinoma. 24 Of the 52 patients studied had jaundice and 28 were without jaundice.

LAP as compared to the other enzymes AST, ALT, GGT, ALP and AST/ALT ratio and GGT/AST ratio showed 100% elevation in obstructive jaundice, carcinoma of gall bladder and pancreas and periampullary carcinoma, 91.7% elevation in hepatocellular carcinoma and 83.3% elevation in liver metastasis. On comparing the levels of these enzymes in non jaundiced and jaundiced groups, LAP was elevated in both jaundiced and non jaundiced groups in 95.8% and 92.9% cases respectively whereas the other enzymes AST showed increase from 67.9% to 100%, ALT from 21.4% to 83.3%, GGT from 71.4% to 95.4% and ALP from 82.1% to 100% in non jaundiced and jaundiced groups respectively indicating that LAP rises in hepatic dysfunction due to hepatobiliary malignancy whereas the other liver function enzymes showed increased hepatic dysfunction due to hepatobiliary malignancy with the onset of jaundice thereby indicating that LAP is a better indicator of hepatobiliary malignancy as compared to other enzymes.

The quantitative methods used for determination are reliable, accurate, simple, rapid and cost effective and therefore have better application in a clinical setting.

Key words: Leucine amino peptidase, carcinoma, liver, biliary tract, pancreas

Full Text

The Full Text of this article is available as a PDF (359.6 KB).

References

  • 1.Smith E.L., Hill R.L. Leucine aminopeptidase. In: Boyer P.D., Lardy H., Myrbak K., editors. The Enzymes. New York and London Inc.: Academic Press; 1960. pp. 37–62. [Google Scholar]
  • 2.Graham E., Goldberg D.M., Spooner R.J., Ward M. Serum enzymes in diseases of the liver and biliary tree. Amer. J. Clin. Pathol. 1978;70:248–258. doi: 10.1093/ajcp/70.2.248. [DOI] [PubMed] [Google Scholar]
  • 3.Schwartz M.K. Enzymes in cancer. Clin. Chem. 1973;19:10–22. [PubMed] [Google Scholar]
  • 4.Khanolkar M.M., Sirsat A.V., Deshmane V.H., Kamat M.R. Serum leucine amino peptidase levels as a marker in testicular turmors. Ind. J. Med. Res. 1992;96:372–375. [PubMed] [Google Scholar]
  • 5.Burstone M.S. Histochemical demonstration of proteolytic activity in human neoplasms. J. Nat. Cancer Inst. 1956;16:1149–1161. [PubMed] [Google Scholar]
  • 6.Glenner G.G., Burstone M.S., Meyer D.B. A study of aminopeptidase activity in the stroma of neoplastic tissue with a comparison of histochemical techniques. J. Nat. Cancer Inst. 1959;23:857–873. [PubMed] [Google Scholar]
  • 7.Suzuki T. Histochemical studies on enzymes in lung tumors. I. Enzyme activities in human lung cancer. Gann. 1966;57:155–167. [PubMed] [Google Scholar]
  • 8.Szasz G. A kinetic photometric method for serum leucine aminopeptidase. Amer. J. Clin. Pathol. 1967;47:607–613. doi: 10.1093/ajcp/47.5.607. [DOI] [PubMed] [Google Scholar]
  • 9.Bergmeyer H.U., Horder M., Rej R.Optimized standard UV method for quantitative determination of aspartate transaminase and alanine transaminase J. Clin. Chem. Clin. Biochem. 198624481–508.3734711 [Google Scholar]
  • 10.Szasz G., Persijn J.P., Coll E.Kinetic Method for quantitative determination of gammaglutamyl transpeptidase Z. Klin. Chem. Klin. Biochem. 197412228–228.4155184 [Google Scholar]
  • 11.Anon (1970) Optimized standard method for quantitative determination of alkaline phosphatase. Z. Klin. Chem. Klin. Biochem. 8, 658. ibid Anon (1970) Optimized standard method for quantitative determination of alkaline phosphatase. Z. Klin. Chem. Klin. Biochem. 8, 658., (1972) 10, 182.
  • 12.Rutenburg A.M., Goldberg J.A., Pineda E.P. Leucine aminopeptidase activity. Observations in patients with cancer of pancreas and other diseases. New Engl. J. Med. 1958;259:469–472. doi: 10.1056/NEJM195809042591003. [DOI] [PubMed] [Google Scholar]
  • 13.Green M.N., Tsou K.C., Bressler R., Seligman A.M. The colorimetric determination of leucine aminopeptidase activity and L-leucyl-b-naphthylamide hydrochloride. Arch. Biochem. 1955;57:458–474. doi: 10.1016/0003-9861(55)90307-6. [DOI] [PubMed] [Google Scholar]
  • 14.Goldberg J.A., Rutenberg A.M. The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other disease. Cancer. 1958;11:283–291. doi: 10.1002/1097-0142(195803/04)11:2<283::AID-CNCR2820110209>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  • 15.Hoffman E., Nachlas M.M., Gaby S.D., Abrams S.J., Seligman A.M. Limitations in the diagnostic value of serum leucine aminopeptidase. New Engl. J. Med. 1960;263:541–544. doi: 10.1056/NEJM196009152631104. [DOI] [PubMed] [Google Scholar]
  • 16.Sathe S.B., Taskar S.P. Leucine aminopeptidase levels in hepatic and certain gastrointestinal tract cancers. 1982;30(2):83–83. [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES